MIT: Rapid Antibody Development Yields Possible Treatment for Yellow Fever
July 30, 2020
July 30, 2020
CAMBRIDGE, Massachusetts, July 30 -- The Massachusetts Institute of Technology issued the following news:
Yellow fever, a hemorrhagic disease that is common in South America and sub-Saharan Africa, infects about 200,000 people per year and causes an estimated 30,000 deaths. While there is a vaccine for yellow fever, it can't be given to some people because of the risk of side effects, and there are no approved treatments for the disease.
An international team of r . . .
Yellow fever, a hemorrhagic disease that is common in South America and sub-Saharan Africa, infects about 200,000 people per year and causes an estimated 30,000 deaths. While there is a vaccine for yellow fever, it can't be given to some people because of the risk of side effects, and there are no approved treatments for the disease.
An international team of r . . .